Application 021088
- Type
- NDA
- Sponsor
- ORTHO MCNEIL JANSSEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIADUR | LEUPROLIDE ACETATE | IMPLANT;IMPLANTATION | EQ 65MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021088-001 | VIADUR | LEUPROLIDE ACETATE | EQ 65MG BASE | IMPLANT / IMPLANTATION | 2000-03-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N021088-001 | VIADUR | EQ 65MG BASE | IMPLANT / IMPLANTATION | 2000-03-03 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N021088-001 | VIADUR | EQ 65MG BASE | IMPLANT / IMPLANTATION | 2000-03-03 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021088-001 | VIADUR | EQ 65MG BASE | IMPLANT / IMPLANTATION | 2000-03-03 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N021088-001 | VIADUR | EQ 65MG BASE | IMPLANT / IMPLANTATION | 2000-03-03 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| leuprolide acetate | LEUPROLIDE ACETATE | Amneal Pharmaceuticals LLC | 4838c674-044e-46b2-81e7-c691b99d8fa5 | 2026-05-28 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Zydus Pharmaceuticals USA Inc. | 35634415-000f-47db-9bd7-9e16eef3f02e | 2026-05-25 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Sandoz Inc | 8bd72c1e-2751-4498-a346-bc5e3acbba0b | 2026-05-19 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Eugia US LLC | 49a1d0c1-304c-46f2-a780-bd940ae1ced0 | 2026-05-08 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Vabrinty | LEUPROLIDE ACETATE | URONOVA PHARMACEUTICALS, INC. | 008776cc-83f1-4f8c-819b-6471425da15f | 2026-04-30 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Eligard | LEUPROLIDE ACETATE | TOLMAR Inc. | b7b679a9-6823-4ef8-8d31-3ab5058ffcfc | 2026-04-30 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| leuprolide acetate | LEUPROLIDE ACETATE | Sun Pharmaceutical Industries, Inc. | a3b01473-30c7-4945-bd60-2484221aaaad | 2026-04-24 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Meitheal Pharmaceuticals Inc | d6bd26bd-b8d8-4c5a-bc5c-7b8a1efaa584 | 2026-04-23 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| leuprolide acetate | LEUPROLIDE ACETATE | UBI Pharma Inc. | cd46628f-055f-4da9-8c38-fa69af34eb4d | 2026-03-29 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Lupron Depot | LEUPROLIDE ACETATE | AbbVie Inc. | cbc8f94e-7330-4465-05ad-16d64493a5dd | 2026-03-15 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Zydus Lifesciences Limited | 4bae0e2a-dd36-4987-85ee-36a52e642ec7 | 2026-02-09 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| leuprolide acetate | LEUPROLIDE ACETATE | PAI Holdings, LLC dba PAI Pharma | 19be0b7f-e68a-4547-9e49-b51b12821907 | 2026-01-16 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | VGYAAN Pharmaceuticals LLC | bec9077a-3f04-4887-856d-dde2de24584d | 2025-11-21 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Lupron Depot-PED | LEUPROLIDE ACETATE | AbbVie Inc. | e99f47d2-da10-3127-ecb3-e5d942ae6e81 | 2025-11-14 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Fensolvi | LEUPROLIDE ACETATE | TOLMAR Inc. | 2c311700-edf4-4f2a-a468-9875489a6cc7 | 2025-09-25 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Lupron Depot | LEUPROLIDE ACETATE | AbbVie Inc. | 00c486b0-bd7b-4898-834d-8c656e5e73cb | 2025-09-18 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Lupron Depot | LEUPROLIDE ACETATE | AbbVie Inc. | 60aad237-e1da-4705-cbbb-b3ca79e89ad8 | 2025-09-10 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | NorthStar RxLLC | 0cf31b40-816b-d055-e063-6294a90af5d0 | 2025-06-24 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LUTRATE DEPOT | LEUPROLIDE ACETATE | Avyxa Pharma, LLC | 3a6d1373-17d9-4289-b62f-d299ffe55831 | 2025-06-03 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE DEPOT | LEUPROLIDE ACETATE | CIPLA USA INC. | 1563a30b-66e0-445d-ba3e-1ccd5218133f | 2024-08-27 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.